tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ADVM Stock Latest News

Adverum Biotechnologies price target lowered to $12 from $16 at Mizuho
The FlyAdverum Biotechnologies price target lowered to $12 from $16 at Mizuho
23d ago
ADVM
Adverum Biotechnologies Holds Annual Meeting with Key Votes
PremiumCompany Announcements
Adverum Biotechnologies Holds Annual Meeting with Key Votes
1M ago
8K
ADVM
Adverum Biotechnologies Reports Q1 2025 Financial Results
PremiumCompany Announcements
Adverum Biotechnologies Reports Q1 2025 Financial Results
2M ago
ADVM
Promising Outlook for Adverum Biotechnologies: Buy Rating on ixo-vec’s Advancements in Wet AMD Treatment
PremiumRatings
Promising Outlook for Adverum Biotechnologies: Buy Rating on ixo-vec’s Advancements in Wet AMD Treatment
2M ago
ADVM
Adverum Biotechnologies price target lowered to $4 from $5 at RBC Capital
PremiumThe Fly
Adverum Biotechnologies price target lowered to $4 from $5 at RBC Capital
2M ago
ADVM
Adverum Biotechnologies reports Q1 EPS ($2.25), consensus ($1.97)
PremiumThe FlyAdverum Biotechnologies reports Q1 EPS ($2.25), consensus ($1.97)
2M ago
ADVM
Adverum Biotechnologies: Promising Gene Therapy Developments and Financial Stability Justify Buy Rating
Premium
Ratings
Adverum Biotechnologies: Promising Gene Therapy Developments and Financial Stability Justify Buy Rating
3M ago
ADVM
Adverum Biotechnologies Reports 2024 Financial Results and Pipeline Progress
Premium
Company Announcements
Adverum Biotechnologies Reports 2024 Financial Results and Pipeline Progress
3M ago
ADVM
Adverum Biotechnologies reports Q4 EPS ($1.96), consensus ($1.38)
PremiumThe Fly
Adverum Biotechnologies reports Q4 EPS ($1.96), consensus ($1.38)
3M ago
ADVM
Adverum Biotechnologies sees cash runway into 2H25
PremiumThe Fly
Adverum Biotechnologies sees cash runway into 2H25
3M ago
ADVM
Adverum Biotechnologies announces anticipated milestones
PremiumThe Fly
Adverum Biotechnologies announces anticipated milestones
3M ago
ADVM
Adverum Biotechnologies Delays Yearly Report Filing
PremiumCompany Announcements
Adverum Biotechnologies Delays Yearly Report Filing
4M ago
ADVM
Adverum Biotechnologies Faces Subtenant Default Situation
PremiumCompany AnnouncementsAdverum Biotechnologies Faces Subtenant Default Situation
4M ago
8K
ADVM
ADVM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ADVM Earnings this Week: How Will it Perform?
4M ago
ADVM
Adverum Biotechnologies initiates ARTEMIS study
Premium
The Fly
Adverum Biotechnologies initiates ARTEMIS study
5M ago
ADVM
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
PremiumThe Fly
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
5M ago
ADVM
FDMT
Adverum Biotechnologies management to meet virtually with Truist
PremiumThe Fly
Adverum Biotechnologies management to meet virtually with Truist
8M ago
ADVM
Adverum Biotechnologies price target lowered to $16 from $20 at Mizuho
PremiumThe Fly
Adverum Biotechnologies price target lowered to $16 from $20 at Mizuho
8M ago
ADVM
Adverum Biotechnologies Advances Ixo-vec Gene Therapy Trials
PremiumCompany Announcements
Adverum Biotechnologies Advances Ixo-vec Gene Therapy Trials
8M ago
8K
ADVM
Adverum Biotechnologies reports results of two trials of Ixo-vec in AMD
PremiumThe FlyAdverum Biotechnologies reports results of two trials of Ixo-vec in AMD
8M ago
ADVM
Adverum Biotechnologies price target lowered to $10 from $12 at RBC Capital
Premium
The Fly
Adverum Biotechnologies price target lowered to $10 from $12 at RBC Capital
9M ago
ADVM
Is ADVM a Buy, Before Earnings?
Premium
Pre-Earnings
Is ADVM a Buy, Before Earnings?
9M ago
ADVM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >